New warnings are raising controversy about the use of antidepressants
December 2004
New warnings are raising controversy about the use of antidepressants...especially in children and teens.
A new black box warning will be added to antidepressant labeling...and every patient will get a "Medication Guide."
The FDA is concerned about an increased risk of suicidal thinking or behavior in some kids...especially when starting antidepressant therapy...or changing the dose.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote